Never Too Late: If you missed the IPKat Last Week! from ipkitten.blogspot.com Dear IPKat followers, if you could not make time for your small IP doses last week, you don’t have to worry! The 156th edition of Never Too Late is here to give you ... Share via E–mail | Twitter | Facebook
It may be use, but is it trade mark use? from ipkitten.blogspot.com One of the most challenging issues in trademark revocation is the claim that while the mark is being used, it is not being used “in a trade mark sense”. Kat friend Anna Toh brings us ... Share via E–mail | Twitter | Facebook
The protection of TV formats: an Italian mock trial from ipkitten.blogspot.com Milan's TriennaleEffective protection of TV formats has often proved a challenging topic, no matter the jurisdiction considered. But what is the situation like in Italy? A few weeks ago I had the pleasure ... Share via E–mail | Twitter | Facebook
The Trump Administration's Intellectual Property and Competition Objectives for NAFTA Renegotiation: What Was Wrong with the TPP? from www.patentdocs.org By Josh Rich -- On July 17, 2017, the United States Trade Representative released the summary of its objectives for NAFTA renegotiation, including its objectives for the intellectual property and competition provisions of the agreement. As ...
Share via E–mail | Twitter | Facebook
Rhetoric vs. Results – A Breakdown of Unified Patents Challenges from gametimeip.com Two of my recent IPWire posts have addressed frequent patent challenger Unified Patents, and their self-appointed mission to profit from the destruction of intellectual property. The first post, in June, exposed Unified Patents IPR results ...
Share via E–mail | Twitter | Facebook
Six Inconvenient Truths About NAFTA Renegotiations from www.ip-watch.org The renegotiation of the North American Free Trade Agreement’s (NAFTA’s) standards on patents is not good news for Canada. Any give by Canada will be costly not only to our health care system ...
Share via E–mail | Twitter | Facebook
WHO Prequalifies First Generic Hepatitis C Drug, First HIV Self-Test from www.ip-watch.org In the lead-up to this month's AIDS conference being held in Paris, the World Health Organization has announced the prequalification of the first generic version of sofosbuvir, a "critical" medicine for treating hepatitis C ...
Share via E–mail | Twitter | Facebook
Denial of Venue Allegations in Answer Preserves Defendant's Venue Challenge from docketreport.blogspot.com The court ordered additional briefing on defendant's motion for judgment on the pleadings of improper venue but found that defendant did not waive its venue defense. "Defendant sufficiently contested and preserved its objection to ...
Share via E–mail | Twitter | Facebook
HBO's Confederate from ipbiz.blogspot.com There is discussion of the HBO show Confederate, an alternate history, which places slavery as a present-day institution in America.
On November 22, 1960, MacKinlay Kantor published an alternate history in LOOK titled If the ...
Share via E–mail | Twitter | Facebook
Comments on unherency in the Millennium decision [ 2017 U.S. App. LEXIS 12702 ] from ipbiz.blogspot.com Dennis Crouch took issue with the inherency portion of the Millennium decision [ 2017 U.S. App. LEXIS 12702 ]:
The easy part of the decision for the district court focused-in on the motivation to combine boronate ... Share via E–mail | Twitter | Facebook
Judge Newman dissent on construction of claim terms with a plain and ordinary meaning from ipbiz.blogspot.com In Nobelbiz, the CAFC reversed ED Texas on claim construction:
Global Connect, L.L.C. and T C N, Inc. (collectively,
the Defendants) appeal from a jury verdict finding they
infringed U.S. Patent Nos ... Share via E–mail | Twitter | Facebook
Ward Law Office at the USPTO – July 21, 2017. from anticipatethis.wordpress.com Ward Law Office had the opportunity to visit the U.S. Patent and Trademark Office (USPTO) on July 21, 2017. After some successful Examiner Interviews, had some spare time before the return flight. So we ...
Share via E–mail | Twitter | Facebook